Towards AI-driven longevity research: An overview
- PMID: 36936271
- PMCID: PMC10018490
- DOI: 10.3389/fragi.2023.1057204
Towards AI-driven longevity research: An overview
Abstract
While in the past technology has mostly been utilized to store information about the structural configuration of proteins and molecules for research and medical purposes, Artificial Intelligence is nowadays able to learn from the existing data how to predict and model properties and interactions, revealing important knowledge about complex biological processes, such as aging. Modern technologies, moreover, can rely on a broader set of information, including those derived from the next-generation sequencing (e.g., proteomics, lipidomics, and other omics), to understand the interactions between human body and the external environment. This is especially relevant as external factors have been shown to have a key role in aging. As the field of computational systems biology keeps improving and new biomarkers of aging are being developed, artificial intelligence promises to become a major ally of aging research.
Keywords: artificial intelligence; biomarkers; deep aging clock; feature selection; longevity medicine; machine learning.
Copyright © 2023 Marino, Putignano, Cappilli, Chersoni, Santuccione, Calabrese, Bischof, Vanhaelen, Zhavoronkov, Scarano, Mazzotta and Santus.
Conflict of interest statement
Authors NM, GP, and AS, were employed by the company Women’s Brain Project (WBP). Authors EB, QV, and AZ were employed by the company Insilico Medicine Hong Kong Ltd. Author ES was employed by company Bayer Corporation. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Alberghina L., Westerhoff H. V. (2007). Systems biology: Definitions and perspectives. Springer Science and Business Media.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
